UTC Bid to Delay Launch of Liquidia’s Yutrepia Shot Down

 A federal judge dismissed United Therapeutics Corp.'s cross-claims against Liquidia Corp. and the US Food and Drug Administration, allowing Liquidia’s lung-disease drug Yutrepia to move forward for a launch as early as this month.

https://news.bloomberglaw.com/ip-law/utc-bid-to-delay-liquidias-yutrepia-launch-shot-down-by-judge